The Gateway to Data Quality: 2026 Sample Rejection Criteria in the Transcriptomics Market
As transcriptomics moves into the core of clinical decision-making, the definition of a "usable sample" has become significantly more stringent. In 2026, the Transcriptomics Market Key Manufacturers are not only providing sequencers but also integrated "Gatekeeper Software" that automatically flags samples failing to meet pre-defined quality thresholds. This shift is essential because the high...
0 Комментарии
0 Поделились
52 Просмотры